Screening of compounds for protecting polyglutamine diseases

筛选预防多聚谷氨酰胺疾病的化合物

基本信息

  • 批准号:
    13557058
  • 负责人:
  • 金额:
    $ 7.68万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

A major hallmark of the polyglutamine (pQ) diseases is the formation of pQ inclusions. Recently, misfolding has come to be considered one of the primary factors for pQ protein aggregation, although, the nature of misfolding and the relationship between misfolding and ubiquitination of the expanded pQ protein is not yet known. By using ataxin-3, the defective gene product of SCA3/MJD, we demonstrated that the cellular toxicity of a pQ protein is directly proportional to the length of the glutamine repeats and inversely dependent on the size of the corresponding protein. The pQ expansion and truncation enhance the reactivity of 1C2 antibody (specific to expanded pQ), chaperone association and ubiquitination, suggesting that pQ expansion and protein truncation enhance the protein misfolding.The protein misfolding induced by pQ expansion was further investigated with our molecular model system using mutant myoglobin which is inserted different size of pQ. Polyglutamine stretches form intra … More molecular β-sheets when pQ expanded and they form intermolecular β-sheets and amyloid fibrils after certain incubation time. The surface of the mutant myoglobin with expanded pQ was partially unfolded and destabilized. We also investigated the early phase of fibrillization of the mutant myoglobin in which 35 or 50 glutamine repeats are inserted. Small-angle X-ray scattering and electron microscopic studies revealed that the expansion of pQ to 50 repeats induced the formation of quasi-aggregate in the earliest stage of the protein fibrillization. We found that β-sheets of pQ in quasi-aggregate were exposed on the surface and were not regularly oriented, as opposed to those in amyloid fibril. X-ray diffraction analysis indicated that the expansion of glutamine repeat did not show substantial effects on the β-sheet structure of pQ in fibril. Since the expansion of glutanine repeat in certain proteins is responsible for pQ diseases, the present study suggests that the condensed and non-oriented β-sheets exposed on the surface of quasi-aggregate, rather than the regularly aligned β-sheets in fibrils, are closely involved in recruitment of various functional proteins into aggregates, leading to the cellular dysfunction that causes pQ diseases. Thus, the quasi-aggregate form also should be targeted to the therapeutic strategy for pQ diseases.Base on those structural change, we searched for compounds to stabilize the molecule with expanded polyglutamine and found some effective compounds. Less
聚谷氨酰胺(PQ)疾病的主要标志是PQ夹杂物的形成。最近,错误折叠已被认为是PQ蛋白聚集的主要因素之一,尽管尚不清楚折叠折叠的性质以及扩展的PQ蛋白的错误折叠和泛素化之间的关系。通过使用SCA3/MJD的有缺陷的基因产物Ataxin-3,我们证明了PQ蛋白的细胞毒性与谷氨酰胺重复序列的长度成正比,并取决于相应蛋白质的大小。 PQ的扩展和截断增强了1C2抗体(特异于扩展的PQ),伴侣关联和泛素化的反应性,这表明PQ膨胀和蛋白质截断增强了蛋白质错误折叠的蛋白质折叠。使用PQ扩展诱导的蛋白质折叠率使用PQ扩展诱导的蛋白质折叠率使用了我们的分子模型系统,该蛋白使用PQ扩展使用了PER,使用了PERTINANS MOTICLANT MONICLOB蛋白。聚谷氨酰胺在PQ扩展时会伸展……更多的分子β-折叠,并在一定的孵育时间后形成分子间β-折叠和淀粉样蛋白纤维。具有扩展PQ的突变体肌红蛋白的表面被部分展开和不稳定。我们还研究了突变体肌球蛋白的纤维化的早期阶段,其中插入了35或50个谷氨酰胺重复。小角度的X射线散射和电子显微镜研究表明,PQ向50个重复的膨胀诱导了蛋白质纤维化最早的准聚集酸盐的形成。我们发现,与淀粉样蛋白原纤维中的PQ相比,与淀粉样蛋白原纤维中的PQ相比,PQ的β-折叠暴露在表面上,并未定期定向。 X射线衍射分析表明,谷氨酰胺重复的膨胀对原纤维中PQ的β-折叠结构没有实质性影响。 Since the expansion of glutanine repeat in certain proteins is responsible for pQ diseases, the present Study suggests that the condensed and non-oriented β-sheets exposed on the surface of quasi-aggregate, rather than the regularly aligned β-sheets in fibrils, are closely involved in recruiting of various functional proteins into aggregates, leading to the cellular dysfunction that causes pQ diseases.这也应针对PQ疾病的治疗策略。在这些结构变化上,我们搜索化合物以稳定分子,并发现了一些有效的化合物。较少的

项目成果

期刊论文数量(62)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iwata, A., Miura, S., Kanazawa, I., Sawada, M., Nukina, N.: "α-synuclein forms a complex with transcription factor Elk-1"J. Neurochem.. 77. 239-252 (2001)
Iwata, A.、Miura, S.、Kanazawa, I.、Sawada, M.、Nukina, N.:“α-突触核蛋白与转录因子 Elk-1 形成复合物”J. Neurochem.. 77. 239-252 ( 2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tanaka, M. et al.: "Intra-and intermolecular β-pleated sheet formation in glutamine-repeat inserted myoglobin as a model for polyglutamine diseases"J.Biol.Chem.. 276. 45470-45475 (2001)
Tanaka, M. 等人:“谷氨酰胺重复插入肌红蛋白中分子内和分子间 β 折叠片的形成作为多谷氨酰胺疾病的模型”J.Biol.Chem.. 276. 45470-45475 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iwata, A., Maruyama, M., Kanazawa, I., Nukina, N.: "α-synuclein affects the MAP kinase pathway and accelerates cell death"J. Biol. Chem.. 276. 45320-45329 (2001)
Iwata, A.、Maruyama, M.、Kanazawa, I.、Nukina, N.:“α-突触核蛋白影响 MAP 激酶途径并加速细胞死亡” J. Biol. 276. 45320-45329 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lee.J-A.et al.: "Aggregate formation and the impairment of long-term synaptic facilitation by ectopic expression of mutant huntingtin in Aplysia neurons"J.Neurochem. (in press). (2003)
Lee.J-A.等人:“海兔神经元中突变型亨廷顿蛋白的异位表达导致聚集形成和长期突触促进的损害”J.Neurochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
貫名信行: "精神神経疾患のDNAチップ解析一緒についたDNAチップ解析"医学のあゆみ. 10. 785-788 (2001)
Nobuyuki Nukina:“DNA 芯片分析以及精神和神经系统疾病的 DNA 芯片分析”《医学史》10. 785-788 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NUKINA Nobuyuki其他文献

NUKINA Nobuyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NUKINA Nobuyuki', 18)}}的其他基金

Establishing the basic study for unmyelinated and myelinated central nervous system
建立无髓鞘和有髓中枢神经系统的基础研究
  • 批准号:
    24659436
  • 财政年份:
    2012
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Polyglutamine diseases: investigation of transcriptional dystregulation
多聚谷氨酰胺疾病:转录失调的研究
  • 批准号:
    22240037
  • 财政年份:
    2010
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study on the mechanism of aggregate formation in neurodegeneration
神经退行性变中聚集体形成机制的研究
  • 批准号:
    17025044
  • 财政年份:
    2005
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Research on Pathomechanisms of Brain Disorders
脑疾病发病机制研究
  • 批准号:
    16071101
  • 财政年份:
    2004
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Proteomic analysis of the pathogenic domain related to aggregate formation
与聚集体形成相关的致病域的蛋白质组学分析
  • 批准号:
    15390279
  • 财政年份:
    2003
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of pathological cascade in CAG repeat disease
CAG重复病的病理级联分析
  • 批准号:
    08457187
  • 财政年份:
    1996
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biochemical study of glial cytoplasmic inclusions in multiple system atrophy brains
多系统萎缩脑胶质细胞质内含物的生化研究
  • 批准号:
    05454258
  • 财政年份:
    1993
  • 资助金额:
    $ 7.68万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

CAG三核苷酸RNA重复序列溶液结构的核磁共振研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
亨廷顿病特异性诱导多能干细胞内CAG拷贝重复程度对移植治疗效果的影响研究
  • 批准号:
    81100946
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigating the Role of Microglia in Huntington’s Disease
研究小胶质细胞在亨廷顿病中的作用
  • 批准号:
    9760991
  • 财政年份:
    2019
  • 资助金额:
    $ 7.68万
  • 项目类别:
Characterization of ATXN2 as a target for ALS in SCA2 motor neurons
ATXN2 作为 SCA2 运动神经元 ALS 靶标的表征
  • 批准号:
    9601486
  • 财政年份:
    2018
  • 资助金额:
    $ 7.68万
  • 项目类别:
Cellular and Molecular Studies of SBMA Neuromuscular Disease
SBMA 神经肌肉疾病的细胞和分子研究
  • 批准号:
    9325082
  • 财政年份:
    2015
  • 资助金额:
    $ 7.68万
  • 项目类别:
Structural polymorphism in the misfolding and aggregation of expanded polyglutamine proteins
扩展的聚谷氨酰胺蛋白错误折叠和聚集的结构多态性
  • 批准号:
    8797828
  • 财政年份:
    2015
  • 资助金额:
    $ 7.68万
  • 项目类别:
Cellular and Molecular Studies of SBMA Neuromuscular Disease
SBMA 神经肌肉疾病的细胞和分子研究
  • 批准号:
    9750819
  • 财政年份:
    2015
  • 资助金额:
    $ 7.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了